Vaccine candidates seeing huge gains.

A good trade to consider is vaccine development companies. Some of the major players are Novavax, Moderna and Giliad. A conservative price target might be 15-25%.
Beyond Technical AnalysisTechnical IndicatorsNVAXTrend Analysis

Disclaimer